John P. Butler - 27 Feb 2023 Form 4 Insider Report for Akebia Therapeutics, Inc. (AKBA)

Role
CEO and President, Director
Signature
/s/ Carolyn Rucci, attorney-in-fact for John P. Butler
Issuer symbol
AKBA
Transactions as of
27 Feb 2023
Net transactions value
-$31,416
Form type
4
Filing time
01 Mar 2023, 15:07:05 UTC
Previous filing
02 Feb 2023
Next filing
03 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AKBA Common Stock Sale $31,416 -38,632 -2.3% $0.8132 1,660,740 27 Feb 2023 Direct F1
holding AKBA Common Stock 100,000 27 Feb 2023 Held By John Butler GRAT November 2019
holding AKBA Common Stock 59,928 27 Feb 2023 Held by John Butler 2019 GRAT
holding AKBA Common Stock 100,000 27 Feb 2023 Held By Dorothy Butler GRAT November 2019
holding AKBA Common Stock 59,928 27 Feb 2023 Held by Dorothy Butler 2019 GRAT
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 26, 2021.